Heterologous expression of G-protein-coupled receptors: Human opioid receptors under scrutiny

Biochimie

Volumn 80, Issue 5-6, 1998, Pages 563-571

  Stanasila, L ^a   Pattus, F ^a   Massotte, D ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Cell lines; G protein coupled receptors; Heterologous expression; Man; Opioid receptors

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; MEMBRANE PROTEIN; OPIATE RECEPTOR;

ARTICLE; BIOCHEMISTRY; GENE EXPRESSION SYSTEM; HUMAN; MOLECULAR STABILITY; NONHUMAN; PHYSICAL CHEMISTRY; PROTEIN PURIFICATION; SIGNAL TRANSDUCTION;

EID: 0032073746     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(00)80021-8     Document Type: Article

References (78)

1. 1 Baldwin JM, Schertler GFX, Unger VM (1997) An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. J Mol Biol 272, 144-164
2. 2 Unger VM, Hargrave PA, Baldwin JM, Schertler GFX (1997) Arrangement of rhodopsin transmembrane α-helices. Nature 389, 203-206
3. 3 Bohm A, Gaudet R, Sigler PB (1997) Structural aspects of heterotrimeric G-protein signaling. Curr Opin Biotechnol 8, 480-487
4. 4 Wess J (1997) G-protein-coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G-protein recognition. FASEB J 11, 346-354
5. 5 Schertler GFX (1992) Overproduction of membrane proteins. Curr Opin Struct Biol 2, 534-544
6. 6 Grisshammer R, Tate CG (1995) Overexpression of integral membrane proteins for structural studies. Q Rev Biophys 28, 315-422
7. 7 Tate CG, Grisshammer R (1996) Heterologous expression of G-protein-coupled receptors. Trends Biotechnol 14, 426-430
8. 8 Kieffer BL (1997) Molecular aspect of opioid receptors: Handbook of Experimental Pharmacology. The Pharmacology of Pain (Dickenson A, Besson JM, eds) Springer-Verlag: Berlin Heidelberg, 281-303
9. 9 Li X, Keith DE, Evans CJ (1996) Mu opioid receptor-like sequences are present throughout vertebrate evolution. J Mol Evol 43, 179-184
10. 10 Knapp RJ, Malatynska E, Collins N, Fang L, Wang JY, Hruby VJ, Roeske WR, Yamamura HI (1995) Molecular cloning and pharmacology of cloned opioid receptors. FASEB J 9, 516-525
11. 11 Alkorta I, Loew GH (1996) A 3D model of the δ opioid receptor and ligand-receptor complexes. Prot Engin 9, 573-583
12. 12 Habibi-Nezhad B, Hanifian M, Mahmoudian M (1996) Computer-aided receptor modelling of human opioid receptors: (mu. kappa & delta) J Mol Model 2, 362-369
13. 13 Strahs D, Weinstein H (1997) Comparative modeling and molecular dynamics studies of the δ, κ and μ opioid receptors. Prot Engin 10, 1019-1038
14. 14 Hoflack J, Trumpp-Kallmeyer S, Hibert M (1994) Re-evaluation of bacteriorhodopsin as a model for G-protein-coupled receptors. Trends Pharmacol 15, 7-9
15. 15 Gimpl G, Burger K, Fahrenholz F (1997) Cholesterol as modulator of receptor function. Biochemistry 36, 10959-10974
16. 16 Rudolph R, Lilie H (1996) In vitro folding of inclusion body proteins. FASEB J 10, 49-56
17. 17 Chen GQ, Gouaux JE (1996) Overexpression of bacterio-opsin in Escherichia coli as a water-soluble fusion to maltose binding protein: efficient regeneration of the fusion protein and selective cleavage with trypsin. Prot Sci 5, 456-67
18. 18 Kiefer H, Krieger J, Olszewski JD, von Heijne G, Prestwich GD, Breer H (1996) Expression of an olfactory receptor in Escherichia coli: purification, reconstitution, and ligand binding. Biochemistry 35, 16077-16084
19. 19 Pedersen-Lane J, Maley GF, Chu E, Maley F (1997) High-level expression of human thymidylate synthase. Prot Exp Purif 10, 256-262
20. 20 Kane JF (1995) Effects of rare codon clusters on high-level expression of heterologous proteins in Escherichia coli. Curr Opin Biotechnol 6, 494-500
21. 21 Makrides SC (1996) Strategies for achieving high-level expression of genes in Escherichia coli. Microbiol Rev 60, 512-538
22. 22 Weickert MJ, Doherty DH, Best EA, Olins PO (1996) Optimization of heterologous protein production in Escherichia coli. Curr Opin Biotechnol 7, 494-499
23. 23 LaVallie ER, McCoy JM (1995) Gene fusion expression systems in Escherichia coli. Curr Opin Biotechnol 6, 501-506
24. 24 Miller JD, Bernstein HD, Walter P (1994) Interaction of E coli Ffh/4.5S ribonucleoprotein and FtsY mimics that of mammalian signal recognition particle and its receptor. Nature 367, 657-659
25. 25 Patel S, Austen BM (1996) Substitution of fifty four homologue (Ffh) in Escherichia coli with the mammalian 54-kDa protein of signal-recognition particle. Eur J Biochem 238, 760-768
26. 26 Marullo S, Delavier KC, Eshdat Y, Strosberg AD, Emorine L (1988) Human beta 2-adrenergic receptors expressed in Escherichia coli membranes retain their pharmacological properties. Proc Natl Acad Sci USA 85, 7551-7555
27. 1A receptor in Escherichia coli. Ligand binding properties and interaction with recombinant G-protein alpha-subunits. J Biol Chem 267, 8200-8206
28. B by Escherichia coli transformants. Biochem Biophys Res Commun 191, 633-638
29. 29 Grisshammer R, Duckworth R, Henderson R (1993) Expression of a rat neurotensin receptor in Escherichia coli. Biochem J 295, 571-576
30. 30 Grisshammer R, Little J, Aharony D (1994) Expression of rat NK-2 (neurokinin A) receptor in E coli. Recept Channels 2, 295-302
31. 31 Jockers R, Linder ME, Hohenegger M, Nanoff C, Bertin B, Strosberg AD, Marullo S, Freissmuth M (1994) Species difference in the G-protein selectivity of the human and bovine A1-adenosine receptor. J Biol Chem 269, 32077-32084
32. 32 Tucker J, Grisshammer R (1996) Purification of a rat neurotensin receptor expressed in Escherichia coli. Biochem J 317, 891-899
33. 33 Talmont F, Sidobre S, Demange P, Milon A, Emorine LJ (1996) Expression and pharmacological characterization of the human μ-opioid receptor in the methylotrophic yeast Pichia pastoris. FEBS Lett 394, 268-272
34. s α subunit. Science 250, 121-123
35. 35 Payette P, Gossard F, Whiteway M, Denis M (1990) Expression and pharmacological characterization of the human M1 muscarinic receptor in Saccharomyces cerevisiae. FEBS Lett 266, 21-25
36. 2s dopamine receptor in the yeasts Saccharomyces cerevisiae and Schizosaccharomyces pombe: a comparative study. FEBS Lett 344, 41-46
37. 2s dopamine receptor in protease-deficient Saccharomyces cerevisiae strains. Eur J Biochem 226, 697-705
38. 38 Huang H-J, Liao C-F, Yang B-C, Kuo T-T (1992) Functional expression of rat M5 muscarinic acetylcholine receptor in yeast. Biochem Biophys Res Commun 182, 1180-1186
39. 39 Ficca AG, Testa L, Tocchini Valentini GP (1995) The human beta 2-adrenergic receptor expressed in Schizosaccharomyces pombe strains retains its pharmacological properties. FEBS Lett 377, 140-144
40. 5A serotonin receptor in the methylotrophic yeast Pichia pastoris: pharmacological characterization and localization. FEBS Lett 377, 451-456
41. 41 Price LA, Kajkowski EM, Hadcock JR, Ozenberger BA, Pausch MH (1995) Functional coupling of a mammalian somatostatin receptor to the yeast pheromone response pathway. Mol Cell Biol 15, 6188-6195
42. 2a adenosine receptor functionally coupled to the yeast pheromone pathway. Mol Pharmacol 50, 829-837
43. 43 Smith GE, Summers MD, Fraser MJ (1983) Production of human β-interferon in insect cells infected with a baculovirus expression vector. Mol Cell Biol 3, 2156-2165
44. 44 O'Reilly DR, Miller LK, Luckow VA (1992) Baculovirus expression vectors. A laboratory manual. WH Freeman and Co, New York
45. 45 Belyaev AS, Roy P (1993) Development of baculovirus triple and quadruple expression vectors: co-expression of three and four bluetongue virus proteins and the synthesis of bluetongue virus-like particles in insect cells. Nucleic Acids Res 21, 1219-1223
46. 46 Ogonah OW, Freedman RB, Jenkins N, Patel K, Rooney BC (1996) Isolation and characterization of an insect cell line able to perform complex N-linked glycosylation on recombinant proteins. Bio/Technol 14, 197-202
47. 47 Jenkins N, Parekh RB, James DC (1996) Getting the glycosylation right: implications for the biotechnology industry. Nature Biotechnol 14, 975-981
48. 48 Massotte D, Baroche L, Simonin F, Yu L, Kieffer B, Pattus F (1997) Characterization of δ, κ and μ human opioid receptors overexpressed in baculovirus-infected insect cells. J Biol Chem 272, 19987-19992
49. 49 Obermeier H, Wehmeyer A, Schulz R (1996) Expression of μ-, δ-and κ-opioid receptors in baculovirus-infected insect cells. Eur J Pharmacol 318, 161-166
50. 50 Guan X-M, Kobilka TS, Kobilka B (1992) Enhancement of membrane insertion and function in a type IIIb membrane protein following introduction of a cleavable signal peptide. J Biol Chem 267, 21995-21998
51. 2s receptor in baculovirus-infected insect cells. Biochemistry 35, 15149-15161
52. 52 Murphy CI, McIntire JR, Davis DV, Hodgdon H, Seals JR, Young E (1993) Enhanced expression, secretion, and large-scale purification of recombinant HIV-1 gp 120 in insect cells using the baculovirus egt and p67 signal peptides. Prot Exp Purif 4, 349-357
53. 53 Kleymann G, Boege F, Hahn M, Hampe W, Vasudevan S, Reiländer H (1993) Human β2-adrenergic receptor produced in stably transformed insect cells in functionally coupled via endogenous GTP-binding protein to adenylyl-cyclase. Eur J Biochem 213, 797-804
54. dro2B. FEBS Lett 381, 233-236
55. 55 Ng GYK, George SR, Zastawny RL, Caron M, Bouvier M, Dennis M, O'Dowd BF (1993) Human serotonin 1B receptor expression in Sf9 cells: phosphorylation, palmitoylation, and adenylyl cyclase inhibition. Biochemistry 32, 11727-11733
56. 1A receptor expressed in insect cells activates endogenous G(o)-like G protein(s). J Biol Chem 269, 12954-12962
57. 57 Quehenberger O, Prossnitz ER, Cochrane CG, Ye RD ( 1992) Absence ofGi proteins in the Sf9 insect cells. J Biol Chem 267, 19757-19760
58. 58 Law PY (1995) G-proteins and opioid receptors functions. Pharmacology of opioid peptides (Tseng LF, ed) Harwood Academic Publishers, Chur, NY, 109-130
59. i2. Biochemistry 35, 15162-15173
60. 60 Mestek A, Hurley JH, Bye LS, Campbell D, Chen Y, Tian M, Liu J, Schulman H, Yu L (1995) The human mu opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C. J Neurosci 15, 501-527
61. 61 Zhang L, Yu Y, Mackin S, Weight FF, Uhl GR, Wang JB (1996) Differential μ opiate receptor phosphorylation and desensitization induced by agonists and phorbol esters. J Biol Chem 271, 11449-11454
62. 32P]GTP labeling of multiple G-protein α subunits. J Neurochem 64, 2534-2543
63. 35S]GTPγS binding: a tool to evaluate functional activity of a cloned opioid receptor transiently expressed in COS cells. Neurochem Res 21, 1301-1307
64. 7 RNA polymerase and the Escherichia coli lac repressor. J Virol 66, 2934-2942
65. 65 Blakely RD, Clark JA, Rudnick G, Amara SG (1991) Vaccinia-T7 RNA polymerase expression system: evaluation for the expression cloning of plasma membrane transporter. Anal Biochem 194, 302-308
66. 66 Liljeström P, Garoff H (1991) A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. BioTechnol 9, 1356-1361
67. 67 Lohse MJ (1992) Stable expression of human β2-adrenergic receptors in mammalian cells. Naunyn-Schmiedeberg's Arch Pharmacol 345, 444-451
68. 68 Befort K, Tabbara L, Kling D, Maigret B, Kieffer BL (1996) Role of aromatic transmembrane residues of the δ-opioid receptor in ligand recognition. J Biol Chem 271, 10161-10168
69. 69 Knapp RJ, Malatynska E, Fang L, Li XP, Babin E, Nguyen M, Santoro G, Varga EV, Hruby VJ, Roeske WR, Yamamura HI (1994) Identification of a human delta opioid receptor: Cloning and expression. Life Sci 54, PL463-469
70. 70 Simonin F, Befort K, Gaveriaux-Ruff C, Matthes H, Nappey V, Lannes B, Micheletti G, Kieffer B (1994) Molecular characterization of the human delta-opioid receptor. Regul Pept 54, 279-280
71. 71 Simonin F, Gavériaux-Ruff C, Befort K, Matthes HWD, Lannes B, Micheletti G, Mattei M-G, Charron G, Bloch B, Kieffer B (1995) Kappa opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology and expression pattern in the central nervous system. Proc Natl Acad Sci USA 92, 7006-7010
72. 72 Zhu J, Chen C, Xue J-C, Kunapuli S, DeRiel JK, Liu-Chen L-Y (1995) Cloning of a human κ opioid receptor from the brain. Life Sci 56, PL201-207
73. 73 Varga EV, Li X, Stropova D, Zalewska T, Landsman RS, Knapp RJ, Malatynska E, Kawai K, Mizusura A, Nagase H, Calderon SN, Rice K, Hruby VJ, Roeske WR, Yamamura HI (1997) The third extracellular loop of the human δ-opioid receptor determines the selectivity of the δ-opioid agonists. Mol Pharmacol 50, 1619-1624
74. 74 Polastron J, Mur M, Mazarguil H, Puget A, Meunier J-C, Jauzac P (1994) SK-N-BE: A human neuroblastoma cell line containing two subtypes of δ-opioid receptors. J Neurochem 62, 898-906
75. 35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol Pharmacol 47, 848-854
76. 76 Malatynska E, Wang Y, Knapp RJ, Santoro G, Li X, Waite S, Roeske WR, Yamamura HI (1995) Human δ opioid receptor: a stable cell line for functional studies of opioids. Neuroreport 6, 613-616
77. 35S]GTPγS binding to membranes: determination of potencies and efficacies of ligands. J Pharmacol Exp Therap 282, 676-684
78. 3H]β-funaltrexamine covalent binding in the cloned rat μ opioid receptor. J Biol Chem 271, 21422-21429